Table 3 Factors associated with changing from a single method of contraception at baseline to dual methods 12 months later among participants in the assessment of family planning practices at 6 hospitals in Thailand, 2008–2009
Characteristics | Use of dual methods at 12 months (n = 317) | RR (95 % CI) | p-value | Adjusted RR (95 % CI) | p-value | |
|---|---|---|---|---|---|---|
Yes (n = 66) | No (n = 251) | |||||
Sexa (no.,%) | ||||||
Female | 36 (19.0) | 154 (81.0) | 1.2 (0.8–1.9) | 0.37 | ||
Male | 30 (23.8) | 96 (76.2) | 1.0 | |||
Age (no.,%) | ||||||
< 29 years | 12 (24.0) | 38 (76.0) | 1.1 (0.4–3.4) | 0.87 | ||
30–39 years | 30 (18.7) | 130 (81.3) | 0.9 (0.3–2.5) | 0.91 | ||
40–49 years | 21 (22.6) | 72 (77.4) | 1.0 (0.4–3.1) | 0.80 | ||
> =50 years | 3 (21.4) | 11 (78.6) | 1.0 | |||
Educationa (no.,%) | ||||||
< =Primary school | 28 (20.6) | 108 (79.4) | 1.0 (0.6–1.5) | 1.0 | ||
> Primary school | 38 (21.2) | 141 (78.8) | 1.0 | |||
Marital status (no.,%) | ||||||
Single | 0 (0.0) | 27 (100.0) | N/A | 0.34 | ||
Married/Live in partner | 65 (23.5) | 211 (76.5) | 3.3 (0.5–22.0) | 0.20 | ||
Divorce/Separated | 1 (7.1) | 13 (92.9) | 1.0 | |||
Disclosure of HIV status to steady partner (no.,%) | ||||||
Yes | 55 (20.2) | 217 (79.8) | 0.8 (0.5–1.4) | 0.65 | ||
No / No partner | 11 (24.4) | 34 (75.6) | 1.0 | |||
Steady partner HIV status (no.,%) | ||||||
Positive | 29 (20.6) | 112 (79.4) | 1.0 (0.6–1.5) | 1.0 | ||
Negative/unknown | 37 (21.0) | 139 (79.0) | 1.0 | |||
Hospital (no.,%) | ||||||
Viangpapao | 4 (20.0) | 16 (80.0) | 1.5 (0.5–4.3) | 0.48 | 1.5 (0.5–4.3) | 0.43 |
Rajvithi | 11 (47.8) | 12 (52.2) | 3.7 (1.9–7.2) | <0.001 | 2.5 (1.1–5.7) | 0.03 |
Siriraj | 26 (32.1) | 55 (67.9) | 2.5 (1.3–4.5) | <0.01 | 2.2 (1.1–4.2) | 0.02 |
BMA (Vajira&Taksin) | 13 (12.9) | 88 (87.1) | 1.0 (0.5–2.0) | 1.0 | 1.0 (0.5–2.1) | 0.98 |
Bamrasnaradura | 12 (13.0) | 80 (87.0) | 1.0 | 1.0 | ||
Time since HIV diagnosis at enrollmenta (no.,%) | ||||||
≥ 5 years | 25 (16.9) | 123 (83.1) | 0.4 (0.2–0.8) | 0.01 | 0.5 (0.2–1.0) | 0.051 |
1–4 years | 28 (20.4) | 109 (79.6) | 0.5 (0.3–0.9) | 0.05 | 0.6 (0.3–1.1) | 0.12 |
< 1 year | 12 (38.7) | 19 (61.3) | 1.0 | 1.0 | ||
CD4a (no.,%) | ||||||
< 200 | 7 (20.6) | 27 (79.4) | 1.0 (0.5–2.1) | 0.10 | ||
> =200 | 54 (19.8) | 219 (80.2) | 1.0 | |||
Ever received ARVa (no.,%) | ||||||
Yes | 45 (17.2) | 217 (82.8) | 0.5 (0.3–0.7) | <0.01 | 0.8 (0.4–1.6) | 0.61 |
No | 20 (37.0) | 34 (63.0) | 1.0 | 1.0 | ||
Received short messages relating to family planning from nurse at enrollment (no.,%) | ||||||
No | 25 (28.7) | 62 (71.3) | 1.6 (1.0–2.5) | .05 | 1.5 (0.9–2.4) | 0.15 |
Yes | 41 (17.8) | 189 (82.2) | 1.0 | 1.0 | ||
Received short messages relating to family planning from doctor at enrollment (no.,%) | ||||||
No | 41 (21.8) | 147 (78.2) | 1.1 (0.7–1.7) | 0.70 | ||
Yes | 25 (19.4) | 104 (80.6) | 1.0 | |||
Received short messages relating to family planning from counselor at enrollment (no.,%) | ||||||
No | 42 (21.2) | 156 (78.8) | 1.0 (0.7–1.6) | 0.94 | ||
Yes | 24 (20.2) | 95 (79.8) | 1.0 | |||